Would you recommend SBRT in the adjuvant settings for a solitary metastasis focus in the abdominal wall resected to R1 in a young and healthy patient with clear cell ovarian cancer?
If so, what dose would you treat to the resection bed?
Answer from: Radiation Oncologist at Community Practice
If it is truly an R1 resection, I would observe and follow with close imaging.If she recurs, I would recommend a discussion for systemic therapy. If she has persistent disease that is amendable to SBRT, it is reasonable to treat. SBRT can prolong a chemotherapy holiday and dosing in the pelvis is us...
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
That depends on the systemic disease status, platinum eligibility, and prior radiation as well as proximity to nearby bowel. 90% of insurers won't cover SBRT without very compelling reasons to (prior disease, no systemic options remaining, etc etc) so outside of a few select institutions, in most pl...
Answer from: Radiation Oncologist at Community Practice
This would be reasonable to proceed with observation. If this is recurrent disease, I would do systemic and close monitoring and treat if suspected recurrence.
I don’t think strictly wrong either though to treat if the target is clear, and no luminal GI nearby.
Answer from: Radiation Oncologist at Academic Institution
Would not treat with adjuvant RT in what is presumably a port-site metastasis. If the patient recurs in a limited fashion, treat at the time of gross disease.
Whether the patient requires systemic therapy now (versus at the time of future recurrence) would be worth a discussion. I would personally ...
Answer from: Radiation Oncologist at Community Practice
I am not aware of any evidence to recommend adjuvant SBRT and I would not treat this patient even if R1 resection, what I presume is a port site recurrence.
The patient's systemic options need to be considered in this case if any. If ok to be not on any systemic therapy, then I would recommen...